 |
|
Complimentary, Certified Lung Cancer CME
Select one of the following topics to schedule your call
(click on a topic to complete a registration form):
• Histology
• Biomarkers
• Maintenance Therapy
|
 |
BALTIMORE, MD—November 29, 2010—Oncologists nationwide are invited to participate in a unique, new CME initiative designed to enhance the care of patients with lung cancer.
Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), announces the launch of the complimentary, certified CME activity, Clinical Conversations: A Personalized Approach for Improving Guideline-Based Care in Non-Small Cell Lung Cancer.
Lung cancer remains the leading cause of cancer death in the United States, and non-small cell lung cancer (NSCLC) accounts for the majority of all lung cancer cases.
“In recent years, several important changes and advances in the understanding and treatment of NSCLC have substantially affected clinical practice,” says George R. Simon, MD, Associate Professor of Medicine and Oncology, The Burtschy Family Distinguished Endowed Chair in Cancer Research, Medical University of South Carolina. “This interactive educational activity provides oncologists with the opportunity to discuss the current body of literature and guideline recommendations as they pertain to these exciting advances and develop strategies to improve patient care.”
Oncologists can now schedule a personalized CME teleconference with one of the national lung cancer experts listed below to review the current evidence and recent clinical advances in the management of NSCLC. During a 30-minute discussion, participants are invited to share their most pressing clinical questions and explore how the latest evidence and updated guidelines can be integrated into their practice for enhanced patient care.
Participants can choose from the following topic areas for discussion:
FACULTY
 |
David R. Gandara, MD – Activity Chair
Professor of Internal Medicine, Hematology and Oncology
University of California, Davis School of Medicine
Associate Director, Clinical Research
Director, Thoracic Oncology Program
University of California, Davis Cancer Center
Sacramento, CA |
 |
Ramaswamy Govindan, MD
Professor of Medicine
Division of Oncology
Washington University School of Medicine
St. Louis, MO |
 |
George R. Simon, MD, FACP, FCCP
Associate Professor of Medicine and Oncology
The Burtschy Family Distinguished Endowed Chair in Cancer Research
Assistant Director, Clinical Investigations, Hollings Cancer Center
Division of Hematology/Oncology, Department of Medicine
Medical University of South Carolina
Charleston, SC
|
This leading-edge educational platform promotes the real-time exchange of ideas and is designed to help address some of the biggest challenges faced in lung cancer patient care today, as well as provide front-line perspective for future CME activities.
This activity is approved for AMA PRA Category 1 Credit™ and is supported by an educational grant from Lilly USA, LLC. For more information, call (toll-free) 866 858 7434 or e-mail info@med-iq.com. About Med-IQ
Med-IQ, recipient of the Alliance for CME’s 2011 William Campbell Felch Award for Research in CME, is an accredited provider of education that inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, visit www.Med-IQ.com, follow us on Twitter, connect with us on LinkedIn, and become a fan on Facebook.
For more information, contact: |
close
